Compare $ALGS vs $ELUT | Chartloom

Compare

$ALGS vs $ELUT

Aligos Therapeutics Inc · Elutia Inc

ALGS

Aligos Therapeutics Inc

ELUT

Elutia Inc

Compare $ALGS vs $ELUT

Comparing Aligos Therapeutics Inc and Elutia Inc

ALGSAligos Therapeutics Inc

ELUTElutia Inc

ALGSAligos Therapeutics Inc

Market cap

$33M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

4.83x

Rev growth (TTM)

893.0%

YTD performance

-41.5%

52W performance

-46.2%

FCF yield

-286.0%

ELUTElutia Inc

Market cap

$36M

P/E (TTM)

0.70x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-48.8%

YTD performance

28.0%

52W performance

-7.4%

FCF yield

-126.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ALGS

ELUT

Detailed metrics comparison

ALGS

Aligos Therapeutics Inc

ELUT

Elutia Inc

Market Cap

ALGS$33M

ELUT$36M

Enterprise Value

ALGS$3M

ELUT$16M

Price

ALGS$5.34

ELUT$0.82

P/E Ratio

ALGSN/A

ELUT0.70x

P/S Ratio

ALGS1.05x

ELUT3.00x

EV/Sales

ALGS0.09x

ELUT1.36x

EV/EBITDA

ALGS0.00x

ELUT0.00x

P/B Ratio

ALGS1.09x

ELUT2.19x

P/FCF Ratio

ALGSN/A

ELUTN/A

EV/FCF

ALGS-0.03x

ELUT-0.36x

PEG Ratio

ALGSN/A

ELUTN/A

Forward P/E (NTM)

ALGSN/A

ELUTN/A

Forward P/S (NTM)

ALGS4.83x

ELUTN/A

Revenue (TTM)

ALGS$32M

ELUT$12M

Revenue Growth (YoY)

ALGS893.0%

ELUT-48.8%

Forward Rev Growth

ALGS-84.9%

ELUT-42.7%

Gross Margin (TTM)

ALGS0.0%

ELUT57.8%

Operating Margin (TTM)

ALGS0.0%

ELUT0.0%

EBITDA Margin (TTM)

ALGS-247.2%

ELUT-163.0%

Net Margin (TTM)

ALGS-241.0%

ELUT426.9%

FCF Margin (TTM)

ALGS-299.9%

ELUT-379.3%

Net Income (TTM)

ALGS$-76M

ELUT$52M

FCF (TTM)

ALGS$-95M

ELUT$-46M

EPS (TTM)

ALGS-$7.28

ELUT$1.17

ROE (TTM)

ALGS-16072.0%

ELUT253.3%

ROA (TTM)

ALGS-9230.0%

ELUT108.7%

ROIC (TTM)

ALGS-16035.0%

ELUT253.3%

Cash

ALGS$30M

ELUT$20M

Debt

ALGS$64K

ELUT$0

Net Cash/Debt

ALGS$30M

ELUT$20M

Current Ratio (TTM)

ALGS2.19x

ELUT1.77x

Quick Ratio (TTM)

ALGS2.19x

ELUT1.58x

Debt/Equity (TTM)

ALGS0.00x

ELUT0.00x

Debt/Assets (TTM)

ALGS0.0%

ELUT0.0%

Interest Coverage (TTM)

ALGSN/A

ELUTN/A

Net Debt/EBITDA (TTM)

ALGS0.00x

ELUT0.00x

Beta

ALGS2.48

ELUT0.97

52W Performance

ALGS-46.2%

ELUT-7.4%

YTD Performance

ALGS-41.5%

ELUT28.0%

% from 52W High

ALGS-61.0%

ELUT-40.6%

% from 52W Low

ALGS34.2%

ELUT64.6%

Asset Turnover (TTM)

ALGS0.38x

ELUT0.25x

FCF Yield (TTM)

ALGS-286.0%

ELUT-126.5%

Earnings Yield (TTM)

ALGS-229.8%

ELUT142.4%

Dividend Yield (TTM)

ALGSN/A

ELUTN/A

Rule of 40

ALGS593.1

ELUT-428.1

EV/GP/RG

ALGSN/A

ELUTN/A

Ticker research

View ALGS research View ELUT research

Metric	ALGS Aligos Therapeutics Inc	ELUT Elutia Inc
Market & Valuation
Market Cap	$33M	$36M
Enterprise Value	$3M	$16M
Price	$5.34	$0.82
P/E Ratio	N/A	0.70x
P/S Ratio	1.05x	3.00x
EV/Sales	0.09x	1.36x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.09x	2.19x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.03x	-0.36x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	4.83x	N/A
Revenue & Growth
Revenue (TTM)	$32M	$12M
Revenue Growth (YoY)	893.0%	-48.8%
Forward Rev Growth	-84.9%	-42.7%
Profitability
Gross Margin (TTM)	0.0%	57.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-247.2%	-163.0%
Net Margin (TTM)	-241.0%	426.9%
FCF Margin (TTM)	-299.9%	-379.3%
Net Income (TTM)	$-76M	$52M
FCF (TTM)	$-95M	$-46M
EPS (TTM)	-$7.28	$1.17
ROE (TTM)	-16072.0%	253.3%
ROA (TTM)	-9230.0%	108.7%
ROIC (TTM)	-16035.0%	253.3%
Financial Health
Cash	$30M	$20M
Debt	$64K	$0
Net Cash/Debt	$30M	$20M
Current Ratio (TTM)	2.19x	1.77x
Quick Ratio (TTM)	2.19x	1.58x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.48	0.97
52W Performance	-46.2%	-7.4%
YTD Performance	-41.5%	28.0%
% from 52W High	-61.0%	-40.6%
% from 52W Low	34.2%	64.6%
Efficiency & Yields
Asset Turnover (TTM)	0.38x	0.25x
FCF Yield (TTM)	-286.0%	-126.5%
Earnings Yield (TTM)	-229.8%	142.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	593.1	-428.1
EV/GP/RG	N/A	N/A
Ticker research	View ALGS research	View ELUT research

Valuation

P/E Ratio

ELUT

0.70x

P/S Ratio

ALGS

1.05x

ELUT

3.00x

EV/FCF

ELUT

-0.36x

ALGS

-0.03x

Growth & revenue

Revenue Growth TTM

ALGS

893.0%

ELUT

-48.8%

Forward Revenue Growth

ELUT

-42.7%

ALGS

-84.9%

Profitability & performance

Gross Margin

ELUT

57.8%

ALGS

0.0%

ROE

ELUT

253.3%

ALGS

-16072.0%

FCF Yield %

ELUT

-126.5%

ALGS

-286.0%

52-Week Performance

ELUT

-7.4%

ALGS

-46.2%

Detailed metrics comparison

ALGS

Aligos Therapeutics Inc

ELUT

Elutia Inc

Market Cap

ALGS$33M

ELUT$36M

Enterprise Value

ALGS$3M

ELUT$16M

Price

ALGS$5.34

ELUT$0.82

P/E Ratio

ALGSN/A

ELUT0.70x

P/S Ratio

ALGS1.05x

ELUT3.00x

EV/Sales

ALGS0.09x

ELUT1.36x

EV/EBITDA

ALGS0.00x

ELUT0.00x

P/B Ratio

ALGS1.09x

ELUT2.19x

P/FCF Ratio

ALGSN/A

ELUTN/A

EV/FCF

ALGS-0.03x

ELUT-0.36x

PEG Ratio

ALGSN/A

ELUTN/A

Forward P/E (NTM)

ALGSN/A

ELUTN/A

Forward P/S (NTM)

ALGS4.83x

ELUTN/A

Revenue (TTM)

ALGS$32M

ELUT$12M

Revenue Growth (YoY)

ALGS893.0%

ELUT-48.8%

Forward Rev Growth

ALGS-84.9%

ELUT-42.7%

Gross Margin (TTM)

ALGS0.0%

ELUT57.8%

Operating Margin (TTM)

ALGS0.0%

ELUT0.0%

EBITDA Margin (TTM)

ALGS-247.2%

ELUT-163.0%

Net Margin (TTM)

ALGS-241.0%

ELUT426.9%

FCF Margin (TTM)

ALGS-299.9%

ELUT-379.3%

Net Income (TTM)

ALGS$-76M

ELUT$52M

FCF (TTM)

ALGS$-95M

ELUT$-46M

EPS (TTM)

ALGS-$7.28

ELUT$1.17

ROE (TTM)

ALGS-16072.0%

ELUT253.3%

ROA (TTM)

ALGS-9230.0%

ELUT108.7%

ROIC (TTM)

ALGS-16035.0%

ELUT253.3%

Cash

ALGS$30M

ELUT$20M

Debt

ALGS$64K

ELUT$0

Net Cash/Debt

ALGS$30M

ELUT$20M

Current Ratio (TTM)

ALGS2.19x

ELUT1.77x

Quick Ratio (TTM)

ALGS2.19x

ELUT1.58x

Debt/Equity (TTM)

ALGS0.00x

ELUT0.00x

Debt/Assets (TTM)

ALGS0.0%

ELUT0.0%

Interest Coverage (TTM)

ALGSN/A

ELUTN/A

Net Debt/EBITDA (TTM)

ALGS0.00x

ELUT0.00x

Beta

ALGS2.48

ELUT0.97

52W Performance

ALGS-46.2%

ELUT-7.4%

YTD Performance

ALGS-41.5%

ELUT28.0%

% from 52W High

ALGS-61.0%

ELUT-40.6%

% from 52W Low

ALGS34.2%

ELUT64.6%

Asset Turnover (TTM)

ALGS0.38x

ELUT0.25x

FCF Yield (TTM)

ALGS-286.0%

ELUT-126.5%

Earnings Yield (TTM)

ALGS-229.8%

ELUT142.4%

Dividend Yield (TTM)

ALGSN/A

ELUTN/A

Rule of 40

ALGS593.1

ELUT-428.1

EV/GP/RG

ALGSN/A

ELUTN/A

Ticker research

View ALGS research View ELUT research

Metric	ALGS Aligos Therapeutics Inc	ELUT Elutia Inc
Market & Valuation
Market Cap	$33M	$36M
Enterprise Value	$3M	$16M
Price	$5.34	$0.82
P/E Ratio	N/A	0.70x
P/S Ratio	1.05x	3.00x
EV/Sales	0.09x	1.36x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.09x	2.19x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.03x	-0.36x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	4.83x	N/A
Revenue & Growth
Revenue (TTM)	$32M	$12M
Revenue Growth (YoY)	893.0%	-48.8%
Forward Rev Growth	-84.9%	-42.7%
Profitability
Gross Margin (TTM)	0.0%	57.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-247.2%	-163.0%
Net Margin (TTM)	-241.0%	426.9%
FCF Margin (TTM)	-299.9%	-379.3%
Net Income (TTM)	$-76M	$52M
FCF (TTM)	$-95M	$-46M
EPS (TTM)	-$7.28	$1.17
ROE (TTM)	-16072.0%	253.3%
ROA (TTM)	-9230.0%	108.7%
ROIC (TTM)	-16035.0%	253.3%
Financial Health
Cash	$30M	$20M
Debt	$64K	$0
Net Cash/Debt	$30M	$20M
Current Ratio (TTM)	2.19x	1.77x
Quick Ratio (TTM)	2.19x	1.58x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.48	0.97
52W Performance	-46.2%	-7.4%
YTD Performance	-41.5%	28.0%
% from 52W High	-61.0%	-40.6%
% from 52W Low	34.2%	64.6%
Efficiency & Yields
Asset Turnover (TTM)	0.38x	0.25x
FCF Yield (TTM)	-286.0%	-126.5%
Earnings Yield (TTM)	-229.8%	142.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	593.1	-428.1
EV/GP/RG	N/A	N/A
Ticker research	View ALGS research	View ELUT research